This is an observational study called the MANAGE-VT Registry for people with Ventricular Tachycardia (VT), a type of irregular heartbeat. The goal is to collect information on how VT is managed using treatments like Ventricular Tachycardia Ablation (a procedure to correct heart rhythm), ICD Implants (pacemakers or defibrillators), and Antiarrhythmic drugs. Researchers will also track diagnostic tests like EKG and Cardioversion. By collecting this data, doctors hope to improve care for VT patients. The study will look at how often VT comes back, the risk of sudden cardiac death, and the prevention of stroke. You can join if you are at least 18 years old. The study is currently collecting data.

Study design

This is an observational study with a planned enrollment of 130 participants. It is not a randomized study, meaning treatments are not assigned by the study.

What's involved

After giving consent, your existing medical data, including VT history, EKG results, echocardiograms, lab results, and information about any VT ablations or ICDs, will be collected. Your anticoagulant medications, date of birth, and zip code will also be recorded.

Compensation

Not stated in the trial record.

Follow-up

The study measures outcomes like VT recurrence, risk of sudden cardiac death, and stroke prevention from July 20, 2020, to the present, indicating ongoing data collection.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.